Core Insights - Chilco River Holdings, Inc. is focusing on enhancing financial transparency and compliance by engaging Solutions Group Accounting to modernize its accounting infrastructure and regulatory systems [1][2] - The partnership aims to strengthen investor confidence, expand access to capital markets, and prepare for audit completion and uplisting initiatives [2][5] Company Strategy - Chilco River is entering a pivotal stage of expansion with strong early market traction in its luxury tequila, premium bourbon, and ready-to-drink (RTD) product lines [6] - The company has completed the acquisition of Excuse Wine & Spirits and is executing a multi-layered growth strategy that includes new product rollouts and expanded distribution channels [6] Financial and Compliance Initiatives - Solutions Group Accounting will assist with full-charge bookkeeping, standardized OTC Markets reporting, quarterly and annual disclosures, and PCAOB audit preparation [5] - The engagement includes fractional CFO leadership for budgeting, forecasting, and capital strategy, as well as strategic planning for a Reg A offering to facilitate future capital raises [5][6]

Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - Magma Silver Corp. (TSXV: MGMA) (OTCQB: MAGMF) (FSE: BC21) (WKN: A411DV) (the "Company" or "Magma") announced that its board of directors has approved the grant of a total of 50,000 incentive stock options (the "Stock Options") to certain of its directors, officers, consultants, and employees pursuant to the Company's Stock Option Plan. Such Stock Options are exercisable into Common Shares at an exercise price of $0.27 per share for a peri ...

Core Points - Mr. Michael Higginson will not stand for election as a Director at the Annual General and Special Meeting on December 16, 2025 [1] - The Board recognizes three Director positions are available, with only three candidates standing for election, and recommends shareholders vote in favor of David Potter [2] - As a result of Mr. Higginson's decision, Resolution 2(c) will be withdrawn from the meeting agenda, but he will continue to serve as Company Secretary and Chief Corporate Officer [3] Company Information - The announcement was authorized for release by the Board of Besra Gold Inc [4]

Group 1 - Excellon Resources Inc. has granted 4,600,000 stock options to its directors and officers under its Share Incentive Plan, with an exercise price of $0.38 per share for three years [1] - The stock options will vest in increments of one-quarter immediately and one-quarter at 6, 12, and 18 months from the grant date [1] Group 2 - Excellon is focused on the potential restart of the Mallay Silver Mine in Peru, alongside a portfolio of exploration-stage projects including Tres Cerros Gold/Silver in Peru, Kilgore in Idaho, and Silver City in Germany [2]

Core Points - SureNano Science Ltd. has granted 1,500,000 stock options to various directors, officers, and consultants, which will vest immediately and can be exercised at CAD $0.18 per share for a period of 5 years [1] - Following this grant, the total stock options represent 4.4% of the outstanding common shares of the Company [2] Company Overview - SureNano Science Ltd. specializes in the sale and distribution of the SureNano™ surfactant, a food-grade compound that enables the creation of high-performance nano-emulsions, enhancing product stability, bioavailability, clarity, and taste [3] - The Company holds an exclusive license to distribute the SureNano™ surfactant in Canada and Colorado, USA [3]

Core Viewpoint - Hertz Energy Inc. is initiating a non-brokered private placement to raise gross proceeds of up to $440,000 through the issuance of units priced at $0.10 each, which will support general administrative expenses and the advancement of its Lake George Antimony project [1][2][3]. Group 1: Private Placement Details - The private placement will consist of up to 4,400,000 units, each unit comprising one common share and one warrant, allowing the purchase of an additional common share at $0.125 within 36 months from the closing date [2]. - The gross proceeds from the offering will be allocated for general and administrative matters and to advance the Lake George Antimony project [3]. - All securities issued will be subject to a statutory hold period of four months and one day following issuance, in accordance with Canadian securities laws [3]. Group 2: Company Overview - Hertz Energy is a junior exploration company based in British Columbia, focused on acquiring and exploring mineral properties in Eastern Canada, with a strategic portfolio targeting lithium and antimony [5]. - The company's lithium assets include the Agastya Lithium Property in Quebec, which is strategically located near significant lithium projects, and the 26,500-hectare AC/DC Project in Quebec's James Bay Lithium District [6]. - The antimony assets consist of the Harriman Property in Quebec's Gaspé Region and the Lake George Property in New Brunswick, both of which are being explored for antimony and gold mineralization [7].

Core Insights - OneMeta Inc. is set to release its 2026 Shareholder Update Video on December 18, 2025, which will outline the company's strategic momentum and priorities for the upcoming year [1][2] - The update will emphasize OneMeta's progress in 2025 and its execution plan for scalable growth in real-time multilingual understanding [3][4] Company Overview - OneMeta specializes in AI-driven multilingual communication technologies, offering solutions such as instant speech-to-speech translation, transcription, and live captioning across over 150 languages [5] - The company's mission is to enhance global communication, making it fast, seamless, secure, and universally accessible [5] Strategic Focus - The 2026 strategy will focus on responsible innovation, disciplined growth, and operational readiness, with advancements in the VerbumSuite platform aimed at improving speed, accuracy, and enterprise integration [8] - OneMeta aims to expand in key verticals where multilingual communication is increasingly essential [8]

Core Viewpoint - Zhibao Technology Inc. has launched a joint venture, Zhibao Yingshi, to enhance the development of medical insurance products in China, leveraging the strengths of both Zhibao and Yingshi Health [1][5]. Company Overview - Zhibao Technology Inc. is a leading InsurTech company focused on digital insurance brokerage services in China, having pioneered the first digital insurance brokerage platform in the country in 2020 [8][9]. - Yingshi Health specializes in health insurance management, emphasizing innovative product design and comprehensive risk control management [10]. Joint Venture Details - The joint venture, Zhibao Yingshi, was established in September 2025, with Zhibao holding a 51% equity interest [3]. - The initial revenue for Zhibao Yingshi was recorded in November 2025, primarily from service fees related to mid- and high-end medical policies [2]. Financial Targets - The joint venture has set preliminary monthly revenue targets of RMB 4 million (approximately USD 560,000) for the remainder of 2025 and an annual revenue target of RMB 50 million (approximately USD 7 million) for 2026, with an expected annual growth rate of no less than 10% [4]. Management and Operations - The management team of Zhibao Yingshi will include Mr. Chunhui Ji from Yingshi Health as chairman and general manager, integrating resources from both companies to achieve growth targets [7][8]. - Zhibao will contribute its existing strengths in reinsurance, brokerage, medical networks, and risk management to the joint venture [7].

Core Viewpoint - MoonLake Immunotherapeutics is facing a securities fraud class action lawsuit due to alleged misrepresentations regarding its clinical data and the efficacy of its investigational drug sonelokimab [1][3][4]. Group 1: Lawsuit Details - A lawsuit has been filed against MoonLake and certain senior executives for potential violations of federal securities laws, specifically under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [1][3]. - Investors have until December 15, 2025, to request to be appointed to lead the case, which is pending in the U.S. District Court for the Southern District of New York [3]. Group 2: Company Background - MoonLake is a clinical-stage biotechnology company focused on developing therapies for inflammatory diseases, particularly through its investigational drug sonelokimab [4]. - The company claimed that its "strong clinical data" from the Phase 2 MIRA trial indicated a higher clinical response for patients, suggesting a competitive advantage over traditional monoclonal antibody treatments [5]. Group 3: Allegations and Impact - The lawsuit alleges that the clinical data and Nanobody structure of sonelokimab did not provide a superior clinical benefit compared to competitors, raising doubts about the drug's regulatory approval and commercial viability [6]. - Following the announcement of disappointing results from the Phase 3 VELA trials, MoonLake's stock price plummeted nearly 90%, from $61.99 per share to $6.24 per share within a few days [7].

Core Viewpoint - Stride, Inc. is facing a class action lawsuit for securities fraud, which has led to significant stock price drops due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - A class action lawsuit has been filed against Stride, Inc. and certain senior executives for securities fraud, with investors encouraged to contact BFA Law by January 12, 2026 [1][3]. - The lawsuit claims violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and is pending in the U.S. District Court for the Eastern District of Virginia [3]. Group 2: Allegations Against Stride - Stride is accused of inflating enrollment numbers by retaining "ghost students" to secure state funding, ignoring compliance requirements, and providing a poor customer experience that led to higher withdrawal rates and lower conversion rates [4][5]. - The company had previously claimed to be experiencing growth and strong demand for its products, which is now being challenged by the allegations [4]. Group 3: Stock Price Impact - Following the fraud allegations reported on September 14, 2025, Stride's stock dropped by $18.60 per share, or over 11%, from $158.36 to $139.76 [5]. - On October 28, 2025, Stride admitted to issues with customer experience, leading to an estimated 10,000-15,000 fewer enrollments, which caused the stock to plummet by $83.48 per share, or more than 54%, from $153.53 to $70.05 [6].